Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$172.43
+2.6%
$185.63
$154.07
$326.00
$45.23B0.952.86 million shs2.35 million shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.22
+2.3%
$5.91
$1.87
$11.40
$617.83M-0.041.12 million shs758,049 shs
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
$3.24
+2.5%
$2.62
$1.45
$3.82
$42.12M1.764,430 shs64,940 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atlassian Corporation PLC stock logo
TEAM
Atlassian
+2.59%-3.01%-7.05%-19.62%+6.24%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
+2.27%+3.74%+27.34%+95.14%-1.50%
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
+2.53%-12.67%+37.29%+67.01%+1.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$172.43
+2.6%
$185.63
$154.07
$326.00
$45.23B0.952.86 million shs2.35 million shs
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
$7.22
+2.3%
$5.91
$1.87
$11.40
$617.83M-0.041.12 million shs758,049 shs
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
$3.24
+2.5%
$2.62
$1.45
$3.82
$42.12M1.764,430 shs64,940 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atlassian Corporation PLC stock logo
TEAM
Atlassian
+2.59%-3.01%-7.05%-19.62%+6.24%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
+2.27%+3.74%+27.34%+95.14%-1.50%
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
+2.53%-12.67%+37.29%+67.01%+1.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atlassian Corporation PLC stock logo
TEAM
Atlassian
2.80
Moderate Buy$256.9048.99% Upside
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
2.60
Moderate Buy$15.61116.20% Upside
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
3.12
Buy$3.24N/A

Current Analyst Ratings Breakdown

Latest TERN, TEAM, TPVE, and YOLO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$7.44
8/20/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
8/18/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$300.00 ➝ $240.00
8/11/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$221.00 ➝ $202.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$230.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$300.00 ➝ $250.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$255.00 ➝ $230.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$256.00 ➝ $240.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$244.00 ➝ $215.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$265.00 ➝ $235.00
8/8/2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$225.00 ➝ $200.00
(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$5.22B8.67N/AN/A$5.12 per share33.68
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/A$4.07 per shareN/A
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atlassian Corporation PLC stock logo
TEAM
Atlassian
-$256.69M-$0.99N/AN/AN/A-4.92%-14.77%-3.28%10/30/2025 (Estimated)
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$88.85M-$1.04N/AN/AN/AN/A-27.35%-26.18%11/11/2025 (Estimated)
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/AN/A21.88N/AN/AN/AN/AN/A

Latest TERN, TEAM, TPVE, and YOLO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q4 2025
Atlassian Corporation PLC stock logo
TEAM
Atlassian
$0.83$0.98+$0.15-$0.09$1.36 billion$1.38 billion
8/5/2025Q2 2025
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
-$0.28-$0.26+$0.02-$0.26N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atlassian Corporation PLC stock logo
TEAM
Atlassian
N/AN/AN/AN/AN/A
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/AN/AN/AN/AN/A
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
$0.041.23%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atlassian Corporation PLC stock logo
TEAM
Atlassian
0.73
1.22
1.22
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
N/A
24.70
24.70
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Atlassian Corporation PLC stock logo
TEAM
Atlassian
94.45%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
98.26%
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Atlassian Corporation PLC stock logo
TEAM
Atlassian
38.55%
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
1.50%
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Atlassian Corporation PLC stock logo
TEAM
Atlassian
13,813262.34 million161.21 millionOptionable
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
4087.51 million86.20 millionNot Optionable
AdvisorShares Pure Cannabis ETF stock logo
YOLO
AdvisorShares Pure Cannabis ETF
N/A13.02 millionN/ANot Optionable

Recent News About These Companies

US cannabis stocks rally as Trump backs rescheduling
Top-Performing ETFs of Last Week

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Atlassian stock logo

Atlassian NASDAQ:TEAM

$172.43 +4.35 (+2.59%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$171.61 -0.82 (-0.47%)
As of 09/5/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams. The company also offers Jira Service Management, an intuitive and flexible service desk product for creating and managing service experiences for various service team providers, such as IT, legal, and HR teams; and Jira Align, an Atlassian's enterprise agility solution designed to help businesses to adapt and respond dynamic business conditions with a focus on value-creation. In addition, it provides Bitbucket, an enterprise-ready Git solution that enables professional dev teams to manage, collaborate, and deploy quality code; Atlassian Access, an enterprise-wide product for enhanced security and centralized administration that works across every Atlassian cloud product; and Jira Product, a prioritization and road mapping tool. Further, the company's portfolio includes Atlas, a teamwork directory; Bamboo, a continuous delivery pipeline; Crowd, a single sign-on; Crucible, a collaborative code review; Fisheye, a search, track, and visualize code change software; and Compass, a developer experience platform. Additionally, it offers Opsgenie, an on-call and alert management software; Sourcetree, a free git client for windows and mac; Statuspage that communicates real-time status to users; Beacon, an intelligent threat detection software; and Atlassian Access that enhance data security and governance for Atlassian Cloud products. The company was founded in 2002 and is headquartered in Sydney, Australia.

Terns Pharmaceuticals stock logo

Terns Pharmaceuticals NASDAQ:TERN

$7.22 +0.16 (+2.27%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$7.22 0.00 (-0.07%)
As of 09/5/2025 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

AdvisorShares Pure Cannabis ETF stock logo

AdvisorShares Pure Cannabis ETF NYSEARCA:YOLO

$3.24 +0.08 (+2.53%)
Closing price 09/5/2025 04:10 PM Eastern
Extended Trading
$3.24 0.00 (0.00%)
As of 09/5/2025 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The AdvisorShares Pure Cannabis ETF (YOLO) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund is an actively-managed ETF that seeks long-term capital appreciation by investing in both domestic and foreign cannabis equities, as well as total return swaps of similar securities. YOLO was launched on Apr 17, 2019 and is managed by AdvisorShares.